Results 11 to 20 of about 3,757,704 (310)

Pre-eclampsia

open access: yesNature Reviews Disease Primers, 2023
Pre-eclampsia is a life-threatening disease of pregnancy unique to humans and a leading cause of maternal and neonatal morbidity and mortality. Women who survive pre-eclampsia have reduced life expectancy, with increased risks of stroke, cardiovascular ...
Nicolaides, Kypros H.   +36 more
core   +4 more sources

The role of genetics in pre-eclampsia and potential pharmacogenomic interventions [PDF]

open access: yesPharmacogenomics and Personalized Medicine, 2012
Paula Juliet Williams, Linda MorganHuman Genetics Research Group, University of Nottingham, Nottingham, UKAbstract: The pregnancy-specific condition pre-eclampsia not only affects the health of mother and baby during pregnancy but also has long-term ...
Williams PJ, Morgan L
doaj   +2 more sources

Not Pre-Eclampsia [PDF]

open access: yesJournal of the Royal Society of Medicine, 2001
By far the commonest cause of hypertension in pregnancy is pre-eclampsia, but other causes must not be forgotten.
S A, Saeed, S, Dean, J V, deGiovanni
openaire   +2 more sources

Preterm and term pre-eclampsia: relative burdens of maternal and perinatal complications. [PDF]

open access: yes, 2022
To determine the relative burdens of maternal and perinatal complications, for preterm and term pre-eclampsia. Prospective observational cohort study. Two English maternity units.
Akolekar, R.   +4 more
core   +1 more source

Endothelial nitric oxide synthase gene polymorphism (Glu298Asp) and development of pre-eclampsia: a case-control study and a meta-analysis. [PDF]

open access: yes, 2006
Background: Pre-eclampsia is thought to have an important genetic component. Recently, pre-eclampsia has been associated in some studies with carriage of a common eNOS gene Glu298Asp polymorphism, a variant that leads to the replacement of glutamic ...
Nicolaides Kypros H   +23 more
core   +2 more sources

In-vitro study of the effect of anti-hypertensive drugs on placental hormones and angiogenic proteins synthesis in pre-eclampsia [PDF]

open access: yes, 2014
Antihypertensive drugs lower the maternal blood pressure in pre-eclampsia (PE) by direct or central vasodilatory mechanisms but little is known about the direct effects of these drugs on placental ...
Muttukrishna, S   +11 more
core   +2 more sources

Midwives’ knowledge of pre-eclampsia management: A scoping review

open access: yes, 2021
Background: Pre-eclampsia is a multi-organ disease affecting pregnant women from the second trimester onwards resulting in multiple adverse outcomes. Sub-optimal treatment of pre-eclampsia is linked with unfavorable outcomes.
Gray, Michelle   +3 more
core   +1 more source

HUBUNGAN USIA IBU, GRAVIDITAS, RIWAYAT PRE-EKLAMPSIA BERAT DI RSUD. KABUPATEN BEKASI PERIODE JUNI 2015- JUNI 2016

open access: yesJurnal Profesi Medika, 2017
Pre-eclampsia/Eclampsia is the second largest cause of maternal death after postpartum hemorrhage. There are some risk factors that influence the occurrence of pre-eclampsia/eclampsia.
Syifa Aulia Luthfiyani   +2 more
doaj   +1 more source

Hypertensive disorders of pregnancy: a systematic review of international clinical practice guidelines. [PDF]

open access: yes, 2014
BACKGROUND: Clinical practice guidelines (CPGs) are developed to assist health care providers in decision-making. We systematically reviewed existing CPGs on the HDPs (hypertensive disorders of pregnancy) to inform clinical practice.
Pels, A   +24 more
core   +1 more source

Uric acid and risk of pre-eclampsia: results from a large case–control study and meta-analysis of prospective studies

open access: yesScientific Reports, 2023
To quantify the association between maternal uric acid levels and pre-eclampsia risk in a large collection of primigravid women. A case–control study (1365 cases of pre-eclampsia and 1886 normotensive controls) was conducted. Pre-eclampsia was defined as
Claudia C. Colmenares-Mejia   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy